Galectin-3 and CD1a-positive dendritic cells are involved in the development of an invasive phenotype in vulvar squamous lesions

被引:12
作者
Brustmann, H [1 ]
机构
[1] Thermenklin Sr Maria, Dept Pathol, A-2340 Vienna, Austria
关键词
vulva; galectin-3; CD1a; dendratic cells; squamous cell carcinoma;
D O I
10.1097/01.pgp.0000179613.40215.c0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
In this study, the expression patterns of Galectin-3 (Gal-3) and the frequency of infiltrating CDla positive dendritic cells (DCs) were determined in 82 cases of vulvar tissues, consisting of normal squamous epithelia (NE, N = 10), vulvar condylomas (VC, N = 24), high grade vulvar intraepithelial neoplasias (HG-VIN, N = 26) of common type, and invasive keratinizing squamous cell carcinomas (SCC, N = 22) by a standard immunohistochemical method using monoclonal antibodies to investigate their differential expression in vulvar squamous dysplasia and infiltrating carcinomas with an emphasis on neoplastic transformation and progression. Gal-3 expression was cytoplasmic, nuclear or membranous in NE, VCs, and HG-VINs, with negative or weak and occasionally moderate reactivities. In SCCs, exclusively cytoplasmic staining patterns with moderate or strong reactivity in 59% of cases were observed (p < 0,0001, chi-square test); Gal-3 expression was not related with stage, grade, and recurrence. The frequency of CDla positive DCs increased from NE and VCs to highest numbers in HG-VINs,was lowest in SCCs (p < 0,0001, ANOVA), and was not related with stage and grade, but with recurrence in SCCs (p = 0,048, t-test). This study indicates that qualitative and quantitative changes of Gal-3 immunoexpression and infiltration by CDla positive DCs in vulvar NE, VCs, and HG-VIN lesions, respectively, compared with SCCs play a role in the development of an infiltrative phenotype, and may provide adjunctive criteria in the diagnosis of invasion of vulvar squamous epithelia.
引用
收藏
页码:30 / 37
页数:8
相关论文
共 35 条
[1]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[2]  
BARONDES SH, 1994, J BIOL CHEM, V269, P20807
[3]   In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas [J].
Bell, D ;
Chomarat, P ;
Broyles, D ;
Netto, G ;
Harb, GM ;
Lebecque, S ;
Valladeau, J ;
Davoust, J ;
Palucka, KA ;
Banchereau, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) :1417-1425
[4]  
BRESALIER RS, 1996, CANCER RES, V56, P4534
[5]  
Clement PB, 2000, ATLAS GYNECOLOGIC SU, P22
[6]  
Creasman WT, 1997, CANCER, V80, P505, DOI 10.1002/(SICI)1097-0142(19970801)80:3<505::AID-CNCR19>3.0.CO
[7]  
2-0
[8]  
Davidson EJ, 2003, CANCER RES, V63, P6032
[9]   Correlation of galectin-3/galectin-3-binding sites with low differentiation status in head and neck squamous cell carcinomas [J].
Delorge, S ;
Saussez, S ;
Pelc, P ;
Devroede, B ;
Marchant, H ;
Burchert, M ;
Zeng, FY ;
Danguy, A ;
Salmon, I ;
Gabius, HJ ;
Kiss, R ;
Hassid, S .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 122 (06) :834-841
[10]   Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer [J].
Eisenthal, A ;
Polyvkin, N ;
Bramante-Schreiber, L ;
Misonznik, F ;
Hassner, A ;
Lifschitz-Mercer, B .
HUMAN PATHOLOGY, 2001, 32 (08) :803-807